Ingrid Reffo

5PUBLICATIONS
15CO-AUTHORS
Major global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Medical virologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 28, 2026
Baseline Predictors of Adverse Outcome and Survival in Adults Hospitalized with Invasive Pneumococcal Disease.

|Jun 16, 2026
Eravacycline in sepsis complicated by Clostridioides difficile infection: a brief case series.

|Jan 17, 2025
Can nCD64 and mCD169 biomarkers improve the diagnosis of viral and bacterial respiratory syndromes in the emergency department? A prospective cohort pilot study.

Sergio Venturini, Massimo Crapis, Agnese Zanus-Fortes

|Dec 18, 2024
Role of MR-proADM and Monocyte CD169 in Predicting In-Hospital and 60-Day Mortality in COVID-19 Patients.

Sergio Venturini, Daniele Orso, Francesco Cugini

|Mar 04, 2024
Clostridium perfringens-induced massive hemolysis treatment with blood purification to target toxins: a case report.

I Reffo, M Domini, M Cevolani

Pageof 1

Frequent Collaborators

4 joint publications

Giovanni Del Fabro

3 joint publications

Sergio Venturini

2 joint publications

Daniele Orso

2 joint publications

Chiara Pratesi